Literature DB >> 6183026

Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies.

A K Ng, P Giacomini, R Kantor, S Ferrone.   

Abstract

This review briefly discusses some recent developments in the use of monoclonal antibodies to study antigens of high molecular mass associated with melanomas, including information on their molecular profile, their heterogeneity, and the effect of interferon on their shedding by melanoma cells.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6183026

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


  5 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  Modulation of melanoma-associated antigens by monoclonal antibodies as visualized by radioimmunoelectron microscopy and radioantibody binding assay.

Authors:  W Tilgen; S Matzku; I Kaufmann; M Engstner; J Brüggen; W Dippold; D Petzoldt
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Characterisation of ocular melanoma with cutaneous melanoma antibodies.

Authors:  J Bomanji; A Garner; J Prasad; D M Albert; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

4.  Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma.

Authors:  D F Schaling; M J van Kroonenburgh; R A Borsje; J A Camps; H M Kakebeeke-Kemme; J A Oosterhuis; E K Pauwels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  A monoclonal antibody against basal cells of human epidermis. Potential use in the diagnosis of cervical neoplasia.

Authors:  V B Morhenn; A B Schreiber; O Soriero; W McMillan; A C Allison
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.